Æterna Zentaris, Inc.(Toronto Stock Exchange : AEZS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.83% | 169.39 | 0.0% | $1421.93m | |
| AMGN | Amgen, Inc. | -0.59% | 254.21 | 1.3% | $686.16m | |
| NVAX | Novavax, Inc. | -1.73% | 223.41 | 80.0% | $644.21m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 8.00 | 0.7% | $559.23m | |
| ILMN | Illumina, Inc. | 0.00% | 399.00 | 3.5% | $519.65m | |
| GILD | Gilead Sciences, Inc. | -0.06% | 66.83 | 1.0% | $470.22m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.12% | 502.00 | 2.7% | $458.19m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.28% | 220.00 | 1.9% | $389.68m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.48% | 164.47 | 2.0% | $349.78m | |
| BNTX | BioNTech SE | 0.29% | 151.98 | 0.0% | $314.48m | |
| BIIB | Biogen, Inc. | 0.00% | 270.31 | 1.7% | $263.29m | |
| EXAS | EXACT Sciences Corp. | -1.99% | 127.45 | 18.4% | $182.48m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.79% | 97.34 | 4.9% | $181.15m | |
| CRSP | CRISPR Therapeutics AG | -0.09% | 118.45 | 0.6% | $166.42m | |
| SGEN | Seagen Inc. | 0.00% | 145.50 | 5.8% | $146.84m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.